Read More

Lineage Cell Therapeutics, Inc. Announces RG6501 Phase 1/2a Results Will Be Featured At 2024 Angiogenesis Exudation And Degeneration Meeting In Presentation By Allen Ho, MD, FACS, FASRS

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that results showing retinal structure

LCTX

Read More

Wall Street Slips As Rate-Cut Hopes Diminish With Inflation, Bitcoin Remains Unmoved By ETF Debut: What’s Driving Markets Thursday?

It’s a bearish Thursday on Wall Street, with stocks relinquishing their gains due to unexpectedly high inflation numbers for December, causing some turbulence in market expectations regarding earlier Federal Reserve rate cuts.<

AAPL

Read More

Mainz Biomed And TestDNA Drive CRC Innovation At The 10th Gdańsk Gastroenterology Symposium On January 12th–13th, 2024 To Discuss Colorectal Cancer – The Need For Earlier Detection

https://www.eqs-news.com/news/corporate/mainz-biomed-and-testdna-drive-crc-innovation-at-the-10th-gdansk-gastroenterology-symposium/1975437Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology

MYNZ